Cardlytics, Inc. (NASDAQ:CDLX) is set to announce second quarter earning results on Tuesday 4th August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, CDLX to report 2Q20 loss of $ 0.47 per share from revenue of $ 30.84 million.
For the full year, analysts anticipate top line of $ 188.00 million, while looking forward to loss of $ 1.1 per share bottom line.
Previous Quarter Performance
Cardlytics, Inc. announced loss for the first quarter of $ 0.26 per share, from the revenue of $ 45.51 million. The quarterly revenues hiked 26.45 percent compared with the same quarter last year. The consensus estimates are loss of $ 0.21 per share from $ 44.21 million in revenue. The bottom line results missed street analysts by $ 0.05 or 23.81 percent, at the same time, top line results outshined analysts by $ 1.30 million or 2.94 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Cardlytics, Inc.
Stock Performance
According to the previous trading day, closing price of CDLX was $ 72.73, representing a 178.98 % increase from the 52 week low of $ 26.07 and a 32.34 % decrease over the 52 week high of $ 107.50.
The company has a market capital of $ 1.96 billion and is part of the Technology sector and Internet Content & Information industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”CDLX” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Recent Analyst recommendations
- On 9th July 2020, maintained by SunTrust Robinson Humphrey at Buy rating, with $ 75.00 target price.
Conference Call
Cardlytics, Inc. will be hosting a conference call at 5:00 PM eastern time on 4th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.cardlytics.com
Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions.